I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AAIC 2024

-
Coming soon
02:30 AM
Duration 1hr Philadelphia, USA
Roche Rater Academy
Peter Deaton, Ruth Croney

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 1hr Philadelphia, USA
Patient Voices
Peter Deaton, Ruth Croney

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:00 PM
Duration 15mins 118 ABC
Novel Approaches to Amyloid: Trontinemab and Beyond
Geoff Kerchner

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4hrs Philadelphia, USA
Assessing Treatment Value Under Uncertainty: Measuring Treatment Value for a New Treatment for Cognitive Impairment
Jason Shafrin, Kyi-Sin Than, Jaehong Kim, Jacob Fajnor, Elizabeth S. Mearns , Stacey L. Kowal, Thomas Majda, Jakub P. Hlavka

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4hrs Philadelphia, USA
Societal Costs of Alzheimer's Disease: Informal Care Partner Cost & Patient Productivity Loss
Julia Fox, Elizabeth S. Mearns, Katherine L. Rosettie, Thomas Majda, Jing Li, Desilu Glazebrook, Nikki Win, Stacey L Kowal

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4hrs Philadelphia, USA
Identifying early predictors of cognitive impairment and dementia in a large nationally-representative US sample
Péter Hudomiet, Michael D. Hurd, Susann Rohwedder

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4hrs Philadelphia, USA
Modeling Early Detection and Geographic Variation in Health System Capacity for Alzheimer’s Disease-Modifying Therapies
Jodi L. Liu, Lawrence Baker, Annie Chen, Jessie Wang, Federico Girosi

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4hrs Philadelphia, USA
Pharmacodynamic effect of a new gamma-secretase modulator, RG6289, on CSF amyloid-beta peptides in a randomized Phase I study
T. Mueggler, A. Portron, A. Vogt, A. Poirier, T. Yang, A. Mohamed Abdi, G. Kollmorgen, N. Wild, C. Simmons, K. Mahil, L. Lindemann, K. Baumann, T. Vardar, R. Tortelli, I. Gerlach, S. Sturm

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 4hrs Philadelphia, USA
Capacity for Alzheimer’s Disease confirmatory testing in the US - current situation and simulations for future increase
Maria-Magdalena Patru, Jessie Yan, Soeren Mattke, Gustaf Ortsaeter, Anders Gustavsson, Sophie Roth

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:30 PM
Duration 1hr Philadelphia, USA
The effect of gantenerumab treatment on brain functional connectivity
Susanna Gobbi, Gregory Klein, Martijn van den Heuvel, and Stefano Magon

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:30 PM
Duration 1hr Philadelphia, USA
Longitudinal effects of gantenerumab treatment on amyloid-PET-derived perfusion estimates in an early AD population
Erica Silvestri, Matteo Tonietto, Susanna Gobbi, Marzia Antonella Scelsi and Gregory Klein

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:15 PM
Duration 15mins 118 ABC
Gamma-secretase modulation from bench to clinic: RG6289 in Alzheimer’s Disease
Irene Gerlach

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar